Commentary: an updated review of the published studies of homocysteine and cardiovascular disease.

Commentary: an updated review of the published studies of homocysteine and cardiovascular disease.

Opis bibliograficzny
1. autor:	Clarke, R
Format:	Journal article
Język:	English
Wydane:	2002

Podobne zapisy

Homocysteine and vascular disease: Review of published results of the homocysteine-lowering trials
od: Clarke, R, i wsp.
Wydane: (2011)

Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials.
od: Clarke, R, i wsp.
Wydane: (2011)

Homocysteine and cardiovascular disease. Overview.
od: Clarke, R
Wydane: (1998)

Homocysteine, B vitamins, and the risk of cardiovascular disease.
od: Clarke, R
Wydane: (2011)

Homocysteine, renal function, and risk of cardiovascular disease.
od: Clarke, R, i wsp.
Wydane: (2003)

Homocysteine-lowering And Cardiovascular Disease: Is The Door Closing Now
od: Clarke, R
Wydane: (2009)

Homocysteine, B-vitamins, and the risk of cardiovascular disease.
od: Clarke, R, i wsp.
Wydane: (2005)

Homocysteine and risk of cardiovascular disease and venous thrombosis
od: Clarke, R, i wsp.
Wydane: (2003)

Homocysteine and cardiovascular disease
od: p yavari
Wydane: (2000-06-01)

Homocysteine and cardiovascular disease
Wydane: (2000-05-01)

Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies.
od: Danesh, J, i wsp.
Wydane: (1998)

Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.
od: Den Heijer, M, i wsp.
Wydane: (2005)

Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.
od: Clarke, R, i wsp.
Wydane: (2001)

Homocysteine, B vitamins, and cardiovascular disease
od: Refsum, H, i wsp.
Wydane: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
od: Refsum, H, i wsp.
Wydane: (2006)

Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.
od: Clarke, R, i wsp.
Wydane: (2007)

Homocysteine and coronary heart disease.
od: Clarke, R, i wsp.
Wydane: (2002)

Homocysteine, the kidney, and vascular disease.
od: Haynes, R, i wsp.
Wydane: (2012)

Homocysteine, the kidney, and vascular disease Moderate differences in homocysteine concentrations do not cause vascular disease
od: Haynes, R, i wsp.
Wydane: (2012)

Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
od: Clarke, R, i wsp.
Wydane: (2000)

Assessment of homocysteine as a cardiovascular risk factor in clinical practice.
od: Clarke, R, i wsp.
Wydane: (2001)

Detecting homocysteine in cardiovascular disease using aptasensors: A review
od: Sara Ranjbari, i wsp.
Wydane: (2023-12-01)

Homocysteine and prediction of coronary heart disease and stroke
od: Clarke, R, i wsp.
Wydane: (2003)

Homocysteine and cardiovascular risk: considering the evidence in the context of study design, folate fortification, and statistical power.
od: Ueland, P, i wsp.
Wydane: (2007)

Homocysteine-lowering trials for prevention of heart disease and stroke.
od: Clarke, R
Wydane: (2005)

Homocysteine, B vitamins, and cardiovascular disease: a Mendelian randomization study
od: Shuai Yuan, i wsp.
Wydane: (2021-04-01)

Homocysteine, grey matter and cognitive function in adults with cardiovascular disease.
od: Andrew H Ford, i wsp.
Wydane: (2012-01-01)

HOMOCYSTEINE, LARGE ARTERIES AND CARDIOVASCULAR RISK
od: Jan Filipovský
Wydane: (2007-08-01)

Elevated plasma total homocysteine increased the risk of dementia in the elderly: Commentary
od: Sheehan, B, i wsp.
Wydane: (2002)

Citation of updated and co-published Cochrane Methodology Reviews
od: Linlin Zhu, i wsp.
Wydane: (2023-07-01)

Homocysteine and Folic Acid: Risk Factors for Alzheimer's Disease—An Updated Meta-Analysis
od: Qianwen Wang, i wsp.
Wydane: (2021-05-01)

Role of Homocysteine in Diseases: A Review
od: Maryam Moradi Binabaj, i wsp.
Wydane: (2016-09-01)

Homocysteine, B vitamins, and the risk of dementia.
od: Clarke, R
Wydane: (2007)

Article Commentary: Retinal Ganglion Cell Loss in Diabetes Associated with Elevated Homocysteine
od: Kenneth S. Shindler
Wydane: (2009-01-01)

Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
od: Clarke, R, i wsp.
Wydane: (1998)

Homocysteine levels and risk of essential hypertension: A meta-analysis of published epidemiological studies
od: Fade Zhong, i wsp.
Wydane: (2017-02-01)

The Impact of Cardiovascular Disease Gene Polymorphism and Interaction with Homocysteine on Deep Vein Thrombosis
od: Lei-Lei Niu, i wsp.
Wydane: (2024-09-01)

Cardiovascular disease among patients with type 2 diabetes: role of homocysteine as an inflammatory marker
od: Ashok Sahu, i wsp.
Wydane: (2016-04-01)

Homocysteine And Neurological Disease
od: Nagaraja D
Wydane: (2004-01-01)

Broken instrument may incidentally be found in second surgery: Update and commentary on a previously published article
od: Ganesh Singh Dharmshaktu, i wsp.
Wydane: (2021-01-01)